Previous Close | 0.9536 |
Open | 0.9563 |
Bid | 0.9602 x 2900 |
Ask | 0.9788 x 3600 |
Day's Range | 0.9538 - 1.0500 |
52 Week Range | 0.8800 - 5.5300 |
Volume | |
Avg. Volume | 8,527,453 |
Market Cap | 187.364M |
Beta (5Y Monthly) | 0.80 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript March 26, 2024 bluebird bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this […]
Key Insights Significant control over bluebird bio by retail investors implies that the general public has more power...
A simultaneous pair of approvals from the U.S. Food and Drug Administration gives investors new factors to consider.